| |
| |
Jack
M. Anthony, CEO |
Osprey
Pharmaceuticals USA |
Jeanne
Bertonis, CEO |
BioSyntech |
| Chu
Chang, VP, International - Asia Pacific |
Genomic Health |
| Andrew
Gengos, VP, Strategy and Corporate Development |
Amgen |
| Juan
Harrison, VP |
Takeda Research
Investment |
| Dr
Phil Haworth, CEO |
Intradigm Corporation |
| Fran
Heller, Executive VP, Business Development |
Exelixis |
| William
Hodder, VP, Business Development |
FibroGen |
| Gary
Hooper, President |
Hooper &
Associates |
| Wendy
Johnson, Venture Partner |
ProQuest Investments |
| Jeff
Jonker, Director, Business Development |
Genentech |
| Tom
Kassberg, Executive VP, Corporate Development |
Proteolix |
| Dr
Kevin Kwok, Executive Recruiter Lifesciences |
Russell Reynolds
Associates |
| Lee
McCracken, Corporate Head, Business Development |
Prometheus Therapeutics
& Diagnostics |
| Gayle
Mills, Executive VP, Business Operations |
ROXRO Pharma |
| Louis
Scotti, VP, Marketing and Business Development |
Arena Pharmaceuticals |
| Dr
Lesley Stolz, VP, Business Development |
Sutro Biopharma |
| Peter
Virsik, Executive Director, Business Development |
XenoPort |
| John Wulf, President |
New Frontier Life Science Consulting |
| |
|
